Generic name: INFLUENZA A VIRUS A/BRISBANE/59/2007(H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) 15ug in 0.5mL, INFLUENZA A VIRUS A/URUGUAY/716/2007(H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) 15ug in 0.5mL, INFLUENZA B VIRUS B/BRISBANE/60/2008 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) 15ug in 0.5mL
Dosage form: injection
Medically reviewed by Drugs.com. Last updated on Jul 23, 2020.
Preparation for Administration
Shake well before administration. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. If either of these conditions exists, the vaccine should not be administered.
Recommended Dose and Schedule
FLUARIX should be administered as an intramuscular injection preferably in the region of the deltoid muscle of the upper arm.
Children: Children 3 years to <9 years of age previously unvaccinated or vaccinated for the first time last season with only one dose receive two 0.5 mL doses; each 0.5 mL dose is administered at least 4 weeks apart.
Children 3 years to <9 years of age who have been previously vaccinated with 2 doses of any influenza vaccine receive only one 0.5 mL dose.
Children 9 years of age and older receive only one 0.5 mL dose.
Adults: Administer as a single 0.5 mL dose.
Do not administer this product intravenously, intradermally, or subcutaneously.
Do not inject in the gluteal area or areas where there may be a major nerve trunk.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Fluarix (influenza virus vaccine, inactivated)
- Side Effects
- During Pregnancy
- Drug Interactions
- Drug class: viral vaccines
- FDA Alerts (1)
- FDA Approval History